• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D filed by Orthofix Medical Inc.

    11/3/23 5:15:22 PM ET
    $OFIX
    Medical/Dental Instruments
    Health Care
    Get the next $OFIX alert in real time by email
    SC 13D 1 sc13d09488ofix_11032023.htm THE SCHEDULE 13D

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 13D

    (Rule 13d-101)

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    (Amendment No. )1

    Orthofix Medical Inc.

    (Name of Issuer)

    Common Stock, $0.10 par value per share

    (Title of Class of Securities)

    68752M108

    (CUSIP Number)

    ANDREW FREEDMAN, ESQ.

    OLSHAN FROME WOLOSKY LLP

    1325 Avenue of the Americas

    New York, New York 10019

    (212) 451-2300

    (Name, Address and Telephone Number of Person

    Authorized to Receive Notices and Communications)

     

    October 24, 2023

    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.

    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    1              The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 68752M108

      1   NAME OF REPORTING PERSON  
             
            ENGINE CAPITAL, L.P.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         2,196,178  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              2,196,178  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            2,196,178  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            6.0%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    2

    CUSIP No. 68752M108

      1   NAME OF REPORTING PERSON  
             
            ENGINE JET CAPITAL, L.P.  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         264,892  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              264,892  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            264,892  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    3

    CUSIP No. 68752M108

     

      1   NAME OF REPORTING PERSON  
             
            ENGINE LIFT CAPITAL, LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            WC  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         227,617  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              227,617  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            227,617  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    4

    CUSIP No. 68752M108

     

      1   NAME OF REPORTING PERSON  
             
            ENGINE CAPITAL MANAGEMENT, LP  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         2,688,687  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              2,688,687  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            2,688,687  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.3%  
      14   TYPE OF REPORTING PERSON  
             
            PN  

      

    5

    CUSIP No. 68752M108

     

      1   NAME OF REPORTING PERSON  
             
            ENGINE CAPITAL MANAGEMENT GP, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         2,688,687  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              2,688,687  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            2,688,687  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.3%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    6

    CUSIP No. 68752M108

     

      1   NAME OF REPORTING PERSON  
             
            ENGINE INVESTMENTS, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         2,461,070  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              2,461,070  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            2,461,070  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            6.7%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    7

    CUSIP No. 68752M108

     

      1   NAME OF REPORTING PERSON  
             
            ENGINE INVESTMENTS II, LLC  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            DELAWARE  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         227,617  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              227,617  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            227,617  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            Less than 1%  
      14   TYPE OF REPORTING PERSON  
             
            OO  

      

    8

    CUSIP No. 68752M108

     

      1   NAME OF REPORTING PERSON  
             
            ARNAUD AJDLER  
      2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐
            (b) ☐
               
      3   SEC USE ONLY    
               
               
      4   SOURCE OF FUNDS  
             
            OO  
      5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e)     ☐
           
               
      6   CITIZENSHIP OR PLACE OF ORGANIZATION  
             
            BELGIUM  
    NUMBER OF   7   SOLE VOTING POWER  
    SHARES          
    BENEFICIALLY         2,688,687  
    OWNED BY   8   SHARED VOTING POWER  
    EACH          
    REPORTING         - 0 -  
    PERSON WITH   9   SOLE DISPOSITIVE POWER  
             
              2,688,687  
        10   SHARED DISPOSITIVE POWER  
               
              - 0 -  
      11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON  
             
            2,688,687  
      12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES     ☐
           
               
      13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
             
            7.3%  
      14   TYPE OF REPORTING PERSON  
             
            IN  

      

    9

    CUSIP No. 68752M108

     

    The following constitutes the Schedule 13D filed by the undersigned (the “Schedule 13D”).

    Item 1.Security and Issuer.

    This statement relates to the Common Stock, $0.10 par value per share (the “Shares”), of Orthofix Medical Inc., a Delaware corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 3451 Plano Parkway, Lewisville, Texas 75056.

    Item 2.Identity and Background.

    (a)       This statement is filed by:

    (i)Engine Capital, L.P., a Delaware limited partnership (“Engine Capital”), with respect to the Shares directly and beneficially owned by it;
    (ii)Engine Jet Capital, L.P., a Delaware limited partnership (“Engine Jet”), with respect to the Shares directly and beneficially owned by it;
    (iii)Engine Lift Capital, LP, a Delaware limited partnership (“Engine Lift”), with respect to the Shares directly and beneficially owned by it;
    (iv)Engine Capital Management, LP, a Delaware limited partnership (“Engine Management”), as the investment manager of each of Engine Capital, Engine Jet and Engine Lift;
    (v)Engine Capital Management GP, LLC, a Delaware limited liability company (“Engine GP”), as the general partner of Engine Management;
    (vi)Engine Investments, LLC, a Delaware limited liability company (“Engine Investments”), as the general partner of each of Engine Capital and Engine Jet;
    (vii)Engine Investments II, LLC, a Delaware limited liability company (“Engine Investments II”), as the general partner of Engine Lift; and
    (viii)Arnaud Ajdler, as the managing partner of Engine Management and the managing member of each of Engine GP, Engine Investments and Engine Investments II.

    Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons.” Each of the Reporting Persons is party to that certain Joint Filing Agreement, as further described in Item 6. Accordingly, the Reporting Persons are hereby filing a joint Schedule 13D.

    (b)       The principal business address of each of Engine Capital, Engine Jet, Engine Lift, Engine Management, Engine GP, Engine Investments, Engine Investments II and Mr. Ajdler is 1345 Avenue of the Americas, 33rd Floor, New York, New York 10105.

    (c)       The principal business of each of Engine Capital, Engine Jet and Engine Lift is investing in securities. Engine Management serves as the investment manager of each of Engine Capital, Engine Jet and Engine Lift. Engine GP serves as the general partner of Engine Management. Engine Investments serves as the general partner of each of Engine Capital and Engine Jet. Engine Investments II serves as the general partner of Engine Lift. Mr. Ajdler serves as the managing partner of Engine Management and the managing member of each of Engine GP, Engine Investments and Engine Investments II.

    10

    CUSIP No. 68752M108

    (d)       No Reporting Person has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

    (e)       No Reporting Person has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

    (f)       Mr. Ajdler is a citizen of Belgium.

    Item 3.Source and Amount of Funds or Other Consideration.

    The Shares purchased by each of Engine Capital, Engine Jet and Engine Lift were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business). The aggregate purchase price of the 2,196,178 Shares beneficially owned by Engine Capital is approximately $26,111,427, including brokerage commissions. The aggregate purchase price of the 264,892 Shares beneficially owned by Engine Jet is approximately $3,154,256, including brokerage commissions. The aggregate purchase price of the 227,617 Shares beneficially owned by Engine Lift is approximately $2,710,831, including brokerage commissions.

    Item 4.Purpose of Transaction.

    The Reporting Persons purchased the Shares based on their belief that the Shares, when purchased, constituted an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.

    The Reporting Persons have engaged, and expect to continue to engage, in discussions with the Issuer’s Board of Directors (the “Board”) regarding certain governance matters.

    The Reporting Persons do not have any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. Depending on various factors including, without limitation, the Issuer’s financial position, results and strategic direction, actions taken by the Issuer’s management and the Board, other investment opportunities available to the Reporting Persons, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in communications and information exchanges with the Issuer’s management and Board, engaging in discussions with shareholders of the Issuer or other third parties about the Issuer and the Reporting Persons’ investment, making recommendations concerning changes to the Issuer’s operations, governance or capitalization, potential business combinations or dispositions involving the Issuer or certain of its businesses, or suggestions for improving the Issuer’s financial and/or operational performance, acquiring additional Shares, disposing of some or all of Shares, or changing their intention with respect to any and all matters referred to in Item 4.

    11

    CUSIP No. 68752M108

    Item 5.Interest in Securities of the Issuer.

    The aggregate percentage of Shares reported owned by each person named herein is based upon 36,738,681 Shares outstanding as of August 4, 2023, which is the total number of Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 8, 2023.

    A.Engine Capital
    (a)As of the date hereof, Engine Capital directly owned 2,196,178 Shares.

    Percentage: Approximately 6.0%

    (b)1. Sole power to vote or direct vote: 2,196,178
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 2,196,178
    4. Shared power to dispose or direct the disposition: 0

     

    B.Engine Jet
    (a)As of the date hereof, Engine Jet directly owned 264,892 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 264,892
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 264,892
    4. Shared power to dispose or direct the disposition: 0

     

    C.Engine Lift
    (a)As of the date hereof, Engine Lift directly owned 227,617 Shares.

    Percentage: Less than 1%

    (b)1. Sole power to vote or direct vote: 227,617
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 227,617
    4. Shared power to dispose or direct the disposition: 0

     

    D.Engine Management
    (a)Engine Management, as the investment manager of each of Engine Capital, Engine Jet and Engine Lift, may be deemed to beneficially own the 2,688,687 Shares owned in the aggregate by Engine Capital, Engine Jet and Engine Lift.

    Percentage: Approximately 7.3%

    12

    CUSIP No. 68752M108

    (b)1. Sole power to vote or direct vote: 2,688,687
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 2,688,687
    4. Shared power to dispose or direct the disposition: 0

     

    E.Engine GP
    (a)Engine GP, as the general partner of Engine Management, may be deemed to beneficially own the 2,688,687 Shares owned in the aggregate by Engine Capital, Engine Jet and Engine Lift.

    Percentage: Approximately 7.3%

    (b)1. Sole power to vote or direct vote: 2,688,687
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 2,688,687
    4. Shared power to dispose or direct the disposition: 0

     

    F.Engine Investments
    (a)Engine Investments, as the general partner of each of Engine Capital and Engine Jet, may be deemed to beneficially own the 2,461,070 Shares owned in the aggregate by Engine Capital and Engine Jet.

    Percentage: Approximately 6.7%

    (b)1. Sole power to vote or direct vote: 2,461,070
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 2,461,070
    4. Shared power to dispose or direct the disposition: 0

     

    G.Engine Investments II
    (a)Engine Investments II, as the general partner of Engine Lift, may be deemed to beneficially own the 227,617 Shares owned by Engine Lift.

    Percentage: Approximately Less than 1%

    (b)1. Sole power to vote or direct vote: 227,617
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 227,617
    4. Shared power to dispose or direct the disposition: 0

     

    H.Arnaud Ajdler
    (a)Mr. Ajdler, as the managing partner of Engine Management and the managing member of each of Engine GP, Engine Investments and Engine Investments II, may be deemed to beneficially own the 2,688,687 Shares owned in the aggregate by Engine Capital, Engine Jet and Engine Lift.

    13

    CUSIP No. 68752M108

    Percentage: Approximately 7.3%

    (b)1. Sole power to vote or direct vote: 2,688,687
    2. Shared power to vote or direct vote: 0
    3. Sole power to dispose or direct the disposition: 2,688,687
    4. Shared power to dispose or direct the disposition: 0

     

    The filing of this Schedule 13D shall not be deemed an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.

    (c)The transactions in the Shares during the past 60 days by certain of the Reporting Persons are set forth on Schedule A attached hereto and are incorporated herein by reference.
    (d)No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
    (e)Not applicable.
    Item 6.Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

    On November 3, 2023, the Reporting Persons entered into a Joint Filing Agreement in which the Reporting Persons agreed to the joint filing on behalf of each of them of statements on Schedule 13D with respect to the securities of the Issuer. The Joint Filing Agreement is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    Other than as described herein, there are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

    Item 7.Material to be Filed as Exhibits.
    99.1Joint Filing Agreement, dated November 3, 2023.

    14

    CUSIP No. 68752M108

     

    SIGNATURES

    After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    Dated: November 3, 2023

      Engine Capital, L.P.
       
      By:

    Engine Investments, LLC,

    General Partner

         
      By:

    /s/ Arnaud Ajdler

        Name: Arnaud Ajdler
        Title: Managing Member

     

     

      Engine Jet Capital, L.P.
       
      By:

    Engine Investments, LLC,

    General Partner

         
      By:

    /s/ Arnaud Ajdler

        Name: Arnaud Ajdler
        Title: Managing Member

     

     

      Engine Lift Capital, LP
       
      By:

    Engine Investments II, LLC,

    General Partner

         
      By:

    /s/ Arnaud Ajdler

        Name: Arnaud Ajdler
        Title: Managing Member

     

     

      Engine Capital Management, LP
       
      By:

    Engine Capital Management GP, LLC,

    General Partner

         
      By:

    /s/ Arnaud Ajdler

        Name: Arnaud Ajdler
        Title: Managing Member

     

    15

    CUSIP No. 68752M108

     

      Engine Capital Management GP, LLC
       
      By:

    /s/ Arnaud Ajdler

        Name: Arnaud Ajdler
        Title: Managing Member

     

     

      Engine Investments, LLC
       
      By:

    /s/ Arnaud Ajdler

        Name: Arnaud Ajdler
        Title: Managing Member

     

     

      Engine Investments II, LLC
       
      By:

    /s/ Arnaud Ajdler

        Name: Arnaud Ajdler
        Title: Managing Member

     

     

     

    /s/ Arnaud Ajdler

      Arnaud Ajdler

     

    16

    CUSIP No. 68752M108

     

    SCHEDULE A

     

    Transactions in the Shares of the Issuer During the Past 60 Days

     

    Nature of Transaction Amount of Securities
    Purchased/(Sold)
    Price per Share ($) Date of Purchase/Sale

     

    ENGINE CAPITAL L.P.

     

    Purchase of Common Stock 122,957 11.0282 10/11/2023
    Purchase of Common Stock 390,561 11.8045 10/12/2023
    Purchase of Common Stock 401,585 12.1932 10/13/2023
    Purchase of Common Stock 455,508 12.8390 10/16/2023
    Purchase of Common Stock 120,538 11.3543 10/23/2023
    Purchase of Common Stock 18,382 11.9561 10/24/2023
    Purchase of Common Stock 256,201 11.9561 10/24/2023
    Purchase of Common Stock 148,105 11.1914 10/25/2023
    Purchase of Common Stock 130,311 10.7786 10/26/2023
    Purchase of Common Stock 8,144 10.6889 10/26/2023
    Purchase of Common Stock 8,144 10.6500 10/26/2023
    Purchase of Common Stock 32,870 10.7718 10/27/2023
    Purchase of Common Stock 55,472 10.7718 10/27/2023
    Purchase of Common Stock 2,997 10.6440 10/30/2023
    Purchase of Common Stock 44,403 10.9615 10/30/2023

     

    ENGINE JET CAPITAL, L.P.

    Purchase of Common Stock 15,085 11.0282 10/11/2023
    Purchase of Common Stock 47,918 11.8045 10/12/2023
    Purchase of Common Stock 49,270 12.1932 10/13/2023
    Purchase of Common Stock 55,886 12.8390 10/16/2023
    Purchase of Common Stock 14,770 11.3543 10/23/2023
    Purchase of Common Stock 2,046 11.9561 10/24/2023
    Purchase of Common Stock 31,394 11.9561 10/24/2023
    Purchase of Common Stock 18,149 11.1914 10/25/2023
    Purchase of Common Stock 15,968 10.7786 10/26/2023
    Purchase of Common Stock 998 10.6889 10/26/2023
    Purchase of Common Stock 998 10.6500 10/26/2023
    Purchase of Common Stock 2 10.7718 10/27/2023
    Purchase of Common Stock 6,691 10.7718 10/27/2023
    Purchase of Common Stock 361 10.6440 10/30/2023
    Purchase of Common Stock 5,356 10.9615 10/30/2023

     

    ENGINE LIFT CAPITAL, LP

     

    Purchase of Common Stock 13,120 11.0282 10/11/2023
    Purchase of Common Stock 41,676 11.8045 10/12/2023
    Purchase of Common Stock 42,852 12.1932 10/13/2023
    Purchase of Common Stock 48,606 12.8390 10/16/2023
    Purchase of Common Stock 12,692 11.3543 10/23/2023
    Purchase of Common Stock 26,977 11.9561 10/24/2023
    Purchase of Common Stock 15,595 11.1914 10/25/2023
    Purchase of Common Stock 13,721 10.7786 10/26/2023
    Purchase of Common Stock 858 10.6889 10/26/2023
    Purchase of Common Stock 858 10.6500 10/26/2023
    Purchase of Common Stock 5,749 10.7718 10/27/2023
    Purchase of Common Stock 311 10.6440 10/30/2023
    Purchase of Common Stock 4,602 10.9615 10/30/2023
           

     

    17

     

      

    Get the next $OFIX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OFIX

    DatePrice TargetRatingAnalyst
    1/22/2025$24.00Buy
    Canaccord Genuity
    11/8/2024$18.00 → $24.00Hold → Buy
    Stifel
    5/8/2024$15.00 → $20.00Neutral → Buy
    ROTH MKM
    10/20/2023$12.00Neutral
    ROTH MKM
    9/12/2023Buy → Neutral
    BTIG Research
    9/12/2023Buy → Hold
    Stifel
    7/19/2023$27.00Buy
    BTIG Research
    3/4/2022$41.00 → $45.00Hold → Buy
    Stifel
    More analyst ratings

    $OFIX
    Leadership Updates

    Live Leadership Updates

    See more
    • Orthofix Announces Appointment of Vickie Capps to Board of Directors

      Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the appointment of Vickie Capps to the Company's Board of Directors, effective March 11, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250312538957/en/Vickie Capps (Photo: Business Wire) "Vickie brings a wealth of experience to our Board at a pivotal stage for Orthofix," said Michael Finegan, Chairman of Orthofix. "Her expertise in global business operations, strategic business development and corporate finance will provide the Board with a tremendously valuable perspective as we seek to deliver profitable growth and significa

      3/12/25 8:00:00 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Patrick Fisher Joins Orthofix as President of Global Orthopedics Business

      Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Patrick Fisher as President of the Orthofix Global Orthopedics business. In this role, Fisher will serve on the company's Executive Leadership team, reporting to Orthofix President and CEO Massimo Calafiore. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240815706187/en/Patrick Fisher, President of Orthofix Global Orthopedics (Photo: Business Wire) Fisher joins Orthofix from Stryker Corporation, a global medical technology company where he served as the Vice President and General Manager of the Foot and Ankle b

      8/15/24 5:52:00 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Orthofix Names Stephanie Walsh Chief Human Resources Officer

      Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Stephanie Walsh as Chief Human Resources Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716004057/en/Stephanie Walsh, Chief Human Resources Officer, Orthofix (Photo: Business Wire) A seasoned human resources executive, Walsh joins Orthofix from ResMed Inc., a San Diego-based medical device company, where she served most recently as Vice President of Transformation. During her tenure at ResMed, she also held multiple HR leadership positions including Vice President, People - SaaS, where she led the H

      7/16/24 7:00:00 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care

    $OFIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Orthofix Reports First Quarter 2025 Financial Results

      Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6-C™ and M6-L™ artificial disc product lines. Highlights First quarter 2025 net sales of $193.6 million, including sales from its M6 artificial cervical and lumbar discs, and pro forma net sales of $189.2 million, excluding sales from its M6 discs, representing an increa

      5/6/25 7:00:00 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Engine Capital Nominates Two Highly Qualified and Independent Candidates for Election to Lyft's Board of Directors at the 2025 Annual Meeting

      Intends to File Preliminary Proxy Statement and Provides Overview of the Case for Shareholder-Driven Change at Lyft Following Years of Value Destruction Engine Capital LP (together with its affiliates, "Engine" or "we"), which owns approximately one percent of the outstanding common shares of Lyft, Inc. (NASDAQ:LYFT) ("Lyft" or the "Company"), today announced that it is filing a preliminary proxy statement in connection with its nomination of two highly qualified and independent candidates – Alan L. Bazaar and Daniel B. Silvers – for election to the Company's Board of Directors (the "Board") at the 2025 Annual Meeting of Shareholders (the "Annual Meeting"). Arnaud Ajdler, Founder and Port

      4/16/25 8:00:00 AM ET
      $AVID
      $FOR
      $HSON
      $IGT
      Computer Software: Prepackaged Software
      Technology
      Real Estate
      Finance
    • Orthofix to Report First Quarter 2025 Financial Results

      Company to Host Conference Call on Tuesday, May 6, 2025 at 8:30 am Eastern Time Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2025 financial results on Tuesday, May 6, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID 7524113. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com. Internet Posting of Information O

      4/15/25 8:00:00 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care

    $OFIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Orthofix Medical Inc.

      SC 13G/A - Orthofix Medical Inc. (0000884624) (Subject)

      11/14/24 5:20:27 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Orthofix Medical Inc.

      SC 13G - Orthofix Medical Inc. (0000884624) (Subject)

      11/13/24 5:03:21 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D/A filed by Orthofix Medical Inc. (Amendment)

      SC 13D/A - Orthofix Medical Inc. (0000884624) (Subject)

      4/22/24 5:00:33 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care

    $OFIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Engine Capital Management, Lp bought $1,231,000 worth of shares (100,000 units at $12.31) (SEC Form 4)

      4 - Orthofix Medical Inc. (0000884624) (Issuer)

      5/8/25 6:38:02 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • President & CEO Calafiore Massimo bought $172,801 worth of shares (9,914 units at $17.43), increasing direct ownership by 5% to 222,404 units (SEC Form 4)

      4 - Orthofix Medical Inc. (0000884624) (Issuer)

      3/6/25 4:27:08 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care

    $OFIX
    SEC Filings

    See more
    • SEC Form 10-Q filed by Orthofix Medical Inc.

      10-Q - Orthofix Medical Inc. (0000884624) (Filer)

      5/6/25 7:05:26 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Orthofix Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Orthofix Medical Inc. (0000884624) (Filer)

      5/6/25 7:03:52 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • SEC Form DEFA14A filed by Orthofix Medical Inc.

      DEFA14A - Orthofix Medical Inc. (0000884624) (Filer)

      4/30/25 4:15:12 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care

    $OFIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity initiated coverage on Orthofix with a new price target

      Canaccord Genuity initiated coverage of Orthofix with a rating of Buy and set a new price target of $24.00

      1/22/25 7:47:50 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Orthofix upgraded by Stifel with a new price target

      Stifel upgraded Orthofix from Hold to Buy and set a new price target of $24.00 from $18.00 previously

      11/8/24 8:23:19 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Orthofix upgraded by ROTH MKM with a new price target

      ROTH MKM upgraded Orthofix from Neutral to Buy and set a new price target of $20.00 from $15.00 previously

      5/8/24 6:31:28 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care

    $OFIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Mcpherron Aviva claimed ownership of 50,050 shares (SEC Form 3)

      3 - Orthofix Medical Inc. (0000884624) (Issuer)

      5/9/25 4:24:43 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Large owner Engine Capital Management, Lp bought $1,231,000 worth of shares (100,000 units at $12.31) (SEC Form 4)

      4 - Orthofix Medical Inc. (0000884624) (Issuer)

      5/8/25 6:38:02 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • New insider Engine Capital Management, Lp claimed ownership of 4,151,671 shares (SEC Form 3)

      3 - Orthofix Medical Inc. (0000884624) (Issuer)

      5/8/25 6:34:36 PM ET
      $OFIX
      Medical/Dental Instruments
      Health Care

    $OFIX
    Financials

    Live finance-specific insights

    See more
    • Orthofix Reports First Quarter 2025 Financial Results

      Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, updated its full-year 2025 net sales guidance, and reaffirmed its full-year 2025 non-GAAP adjusted EBITDA and positive free cash flow guidance. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue its M6-C™ and M6-L™ artificial disc product lines. Highlights First quarter 2025 net sales of $193.6 million, including sales from its M6 artificial cervical and lumbar discs, and pro forma net sales of $189.2 million, excluding sales from its M6 discs, representing an increa

      5/6/25 7:00:00 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Orthofix to Report First Quarter 2025 Financial Results

      Company to Host Conference Call on Tuesday, May 6, 2025 at 8:30 am Eastern Time Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its first quarter 2025 financial results on Tuesday, May 6, 2025 before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing (888) 596-4144 in the U.S., and (646) 968-2525 in all other locations, and referencing the conference ID 7524113. A webcast of the conference call and a copy of the release may be accessed at ir.Orthofix.com. Internet Posting of Information O

      4/15/25 8:00:00 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care
    • Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance

      Record Results Reflect Strong Execution as Company Focuses on Most Profitable Growth Opportunities in Spine, Orthopedics and Bone Growth Therapies Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2024, and provided full-year 2025 financial guidance. Highlights Record fourth quarter 2024 net sales of $215.7 million, an increase of 8% on a reported and constant currency basis compared to fourth quarter 2023 U.S. Spine Fixation1 net sales growth of 12% compared to fourth quarter 2023, driven by distribution expansion and further penetration in existing account

      2/25/25 7:00:00 AM ET
      $OFIX
      Medical/Dental Instruments
      Health Care